Yimutian Faces Nasdaq Delisting, Discloses New MVLS Deficiency Amidst Highly Dilutive Resale Program

summarizeSummary

Yimutian Inc. received a formal Nasdaq delisting determination for failing to meet the minimum market value of publicly held shares and a new notification for not meeting the minimum market value of listed securities, while also updating a prospectus for a highly dilutive $10 million resale of ADSs.

check_boxKey Events

• Nasdaq Delisting Determination

  The company received a formal determination letter from Nasdaq on May 13, 2026, for failing to regain compliance with the minimum market value of publicly held shares (MVPHS) requirement by May 6, 2026. This follows a previous notification on November 6, 2025.

• New MVLS Deficiency Notice

  Yimutian also received a new notification on May 13, 2026, for not complying with Nasdaq's minimum market value of listed securities (MVLS) requirement of $50 million. The company has until November 9, 2026, to regain compliance.

• Appeal to Stay Delisting

  The company intends to file an appeal, which will stay any further delisting proceedings through the hearing process, allowing its ADSs to continue trading on Nasdaq Global Market for now.

• Highly Dilutive Resale Program

  This prospectus supplement updates an existing program for the resale of up to 42,307,692 ADSs, representing shares issuable upon conversion of up to $10 million in senior convertible promissory notes. This represents over 65% of the current market capitalization, indicating significant potential dilution.

auto_awesomeAnalysis

This filing confirms Yimutian's severe financial distress and heightened delisting risk. The company has received a formal delisting determination from Nasdaq for failing to meet the minimum market value of publicly held shares, and a new notification for not meeting the minimum market value of listed securities. While an appeal will temporarily stay delisting, the company's market capitalization is significantly below Nasdaq's requirements. Concurrently, the ongoing resale program for up to $10 million in ADSs from convertible notes represents substantial potential dilution, equivalent to over 65% of the current market cap, further pressuring the stock price and making compliance with listing rules more challenging.